GENEVA, Switzerland, and NEW YORK, N.Y., April 5, 2022 (SEND2PRESS NEWSWIRE) — Neurosoft Bioelectronics, an early-stage company developing tools for unmet needs in epilepsy and tinnitus, was awarded nearly $3 million USD, from the SERI-Funded European Innovation Council Accelerator Grant and a share of the $165,000 USD through the European Research Council Proof-of-Concept Grant.
Archive | Biotechnology
Press Release: Key Entrepreneurs to Present at 2022 Bioelectronic Medicine Forum
By Send2Press Newswire on March 28, 2022 in Biotechnology, Business, NEW YORK, N.Y., Press Releases, Regional Events, Surgery and Neurotechnology, Technology
NEW YORK, N.Y., March 28, 2022 (SEND2PRESS NEWSWIRE) — Neurotech Reports, the publisher of the Neurotech Business Report and BioElectRx Business Report newsletters, announced that founders and CEOs of several promising bioelectronic medicine startups will present at the Fifth Annual Bioelectric Medicine Forum on April 5, 2022. The event will take place in New York […]
Press Release: Kalyagen Announces Supporting Partnership of Two South Florida PGA Events and PGA Associate Jerrel Gill
By Send2Press Newswire on March 10, 2022 in Alliances and Partnerships, AUSTIN, Texas, Biotechnology, Business, Golf, Press Releases, Sports and Activities
AUSTIN, Texas, March 10, 2022 (SEND2PRESS NEWSWIRE) — Kalyagen® is pleased to announce that it is a supporting partner of two upcoming South Florida PGA Section events and golf professional Jerrel Gill. The two events are the South Florida PGA Foundation PGA HOPE Classic on May 12, 2022 and the South Florida Open on June […]
Press Release: Pure Transplant Solutions, LLC and Vall d’Hebron University Hospital Announce Research Collaboration
By Send2Press Newswire on February 15, 2022 in Alliances and Partnerships, AUSTIN, Texas, Biotechnology, Business, Press Releases
AUSTIN, Texas and BARCELONA, Spain, Feb. 15, 2022 (SEND2PRESS NEWSWIRE) — Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a research collaboration with Vall d’Hebron Barcelona Hospital […]
Press Release: Pure Transplant Solutions, LLC and Oxford Immunotec, Ltd. Announce Exclusive Sublicense Agreement to Support Commercialization of Novel B Cell Measurement Assay for Early Detection of Tissue Injury and Prevention of Organ Rejection
By Send2Press Newswire on December 7, 2021 in Alliances and Partnerships, AUSTIN, Texas, Biotechnology, Business, Press Releases
AUSTIN, Texas and OXFORD, U.K., Dec. 7, 2021 (SEND2PRESS NEWSWIRE) — Pure Transplant Solutions, LLC (PTS), a developer of novel HLA based transplant diagnostics, and Oxford Immunotec, Ltd. (OI), a global diagnostics company part of PerkinElmer Inc., today announce an exclusive sublicense agreement in which PTS will obtain exclusive commercial rights to issued patents protecting […]
Press Release: Neurotech Reports Announces Launch of New Publication Serving Bioelectronic Medicine Industry
By Send2Press Newswire on November 8, 2021 in Biotechnology, Books and Publishing, Business, Press Releases, Product Launches, SAN FRANCISCO, Calif.
SAN FRANCISCO, Calif., Nov. 8, 2021 (SEND2PRESS NEWSWIRE) — Neurotech Reports, the San Francisco, California publisher of market intelligence for the healthcare industry, announced the launch of a new monthly newsletter covering the bioelectronic medicine industry, one of the newest and fastest growing industry segments. The publication, BioElectRx Business Report, is the first industry newsletter […]
Press Release: Kalyagen™ Announces Registration of STEMREGEN® in Spain, CEO at Madrid Stem Cell Symposium
By Send2Press Newswire on October 12, 2021 in AUSTIN, Texas, Biotechnology, Business, Press Releases
AUSTIN, Texas, Oct. 12, 2021 (SEND2PRESS NEWSWIRE) — Kalyagen is pleased to announce the successful product registration of STEMREGEN® in Spain. This announcement coincides with Christian Drapeau’s, CEO and Chief Scientist of Kalyagen, trip to Madrid, Spain last week to speak at the IV Jornadas Internacionales Otto H. Warburg symposium at the NH Madrid Príncipe […]
Press Release: iCell Gene Therapeutics Announces cCAR-T Clinical Publication in the Stem Cell Reviews and Reports Journal
By Send2Press Newswire on September 10, 2021 in Biotechnology, Business, Drugs and Pharmaceuticals, Press Releases, Reports and Studies
STONY BROOK, N.Y., Sept. 10, 2021 (SEND2PRESS NEWSWIRE) — iCell Gene Therapeutics, a clinical stage biopharmaceutical company focused on immunotherapies for hematologic malignancies, solid tumors, organ rejections and autoimmune disorders, today announced the publication of their clinical study utilizing cCAR T-cell immunotherapy to successfully treat a patient with lupus.
Press Release: Vyriad, Inc. Appoints Harry Hoffman to its Board of Directors
ROCHESTER, Minn., Aug. 24, 2021 (SEND2PRESS NEWSWIRE) — Vyriad, Inc., a clinical-stage biotechnology company developing oncolytic virus therapies to treat a wide range of cancers, today announced the appointment of leading life sciences investor Harry Hoffman to the Company’s board of directors.
Press Release: KROST Acts as Exclusive Financial Advisor for Integrity Bio in Sale to Curia
By Send2Press Newswire on August 11, 2021 in Biotechnology, Business, Consulting, Finance, LOS ANGELES, Calif., Mergers and Acquisitions, Press Releases, Taxes and Accounting
LOS ANGELES, Calif., Aug. 11, 2021 (SEND2PRESS NEWSWIRE) — Integrity Bio, Inc., a privately held formulation and fill-finish organization, was sold to Curia (formerly Albany Molecular Research, Inc. (AMRI)), a Contract Development and Manufacturing Organization (CDMO) and leading global provider of advanced contract research, development, and manufacturing solutions. KROST, a Los Angeles-based firm, acted as […]